JP2004537500A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537500A5 JP2004537500A5 JP2002555834A JP2002555834A JP2004537500A5 JP 2004537500 A5 JP2004537500 A5 JP 2004537500A5 JP 2002555834 A JP2002555834 A JP 2002555834A JP 2002555834 A JP2002555834 A JP 2002555834A JP 2004537500 A5 JP2004537500 A5 JP 2004537500A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- patient
- nature
- body weight
- per
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69360000A | 2000-10-20 | 2000-10-20 | |
| US31818501P | 2001-09-07 | 2001-09-07 | |
| PCT/US2001/051339 WO2002055100A2 (en) | 2000-10-20 | 2001-10-22 | Method and composition for inhibition of tumor growth and enhancing an immune response |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008262301A Division JP2009046512A (ja) | 2000-10-20 | 2008-10-08 | 腫瘍の増殖の阻害および免疫応答の増強のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537500A JP2004537500A (ja) | 2004-12-16 |
| JP2004537500A5 true JP2004537500A5 (enExample) | 2005-04-21 |
Family
ID=26981351
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002555834A Pending JP2004537500A (ja) | 2000-10-20 | 2001-10-22 | 腫瘍の増殖の阻害および免疫応答の増強のための方法および組成物 |
| JP2008262301A Pending JP2009046512A (ja) | 2000-10-20 | 2008-10-08 | 腫瘍の増殖の阻害および免疫応答の増強のための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008262301A Pending JP2009046512A (ja) | 2000-10-20 | 2008-10-08 | 腫瘍の増殖の阻害および免疫応答の増強のための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP1333850B1 (enExample) |
| JP (2) | JP2004537500A (enExample) |
| AT (1) | ATE405282T1 (enExample) |
| AU (1) | AU2002243443A1 (enExample) |
| DE (1) | DE60135481D1 (enExample) |
| DK (1) | DK1333850T3 (enExample) |
| ES (1) | ES2311558T3 (enExample) |
| WO (1) | WO2002055100A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050069546A1 (en) * | 2003-09-30 | 2005-03-31 | Yaron Ilan | Educated NKT cells and their uses in the treatment of immune-related disorders |
| JP4943161B2 (ja) | 2003-12-23 | 2012-05-30 | ジェネンテック， インコーポレイテッド | 新規抗ｉｌ１３モノクローナル抗体での癌の処置 |
| WO2005091853A2 (en) * | 2004-02-27 | 2005-10-06 | Centocor, Inc. | Methods and compositions for treating il-13 related pathologies |
| AR049390A1 (es) | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
| US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
| JP2008520684A (ja) | 2004-11-17 | 2008-06-19 | アブジェニックス・インコーポレーテッド | Ｉｌ−１３に対する完全ヒトモノクローナル抗体 |
| JP2008528643A (ja) * | 2005-02-04 | 2008-07-31 | スルバック アーぺーエス | サバイビンペプチドワクチン |
| PL3339445T3 (pl) | 2006-09-08 | 2020-12-14 | Abbvie Bahamas Ltd. | Białka wiążące interleukinę 13 |
| US20120177668A1 (en) * | 2009-07-06 | 2012-07-12 | The Australian National University | Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
| EP2652498B1 (en) | 2010-12-16 | 2018-04-18 | F.Hoffmann-La Roche Ag | Diagnosis and treatments relating to th2 inhibition |
| CA2811203C (en) | 2011-10-21 | 2015-05-05 | Abbvie Inc. | Methods for treating hcv |
| US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
| CN104023726A (zh) | 2011-10-21 | 2014-09-03 | 艾伯维公司 | 用于治疗hcv的一种或多种daa的联合治疗(例如，与abt-072或abt-333) |
| US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
| EP3683232A1 (en) | 2013-09-13 | 2020-07-22 | F. Hoffmann-La Roche AG | Methods and compositions comprising purified recombinant polypeptides |
| RU2016107435A (ru) | 2013-09-13 | 2017-10-18 | Дженентек, Инк. | Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты |
| US20170165364A1 (en) * | 2014-02-21 | 2017-06-15 | Idac Theranostics, Inc. | Therapeutic agent for solid cancer |
| JP7129703B2 (ja) | 2016-04-28 | 2022-09-02 | エモリー ユニバーシティー | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 |
| EP4743487A1 (en) * | 2023-07-12 | 2026-05-20 | Henry M Jackson Found Advancement Military Medicine Inc | Compositions and methods of inhibiting natural killer cells |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294322B1 (en) | 1988-01-26 | 2001-09-25 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| EP0656947A1 (en) * | 1992-08-21 | 1995-06-14 | Schering Corporation | Human interleukin-13 |
| US20010053371A1 (en) * | 1999-01-07 | 2001-12-20 | Waldemar Debinski | Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| JPH09150569A (ja) | 1995-11-29 | 1997-06-10 | Riso Kagaku Corp | 色画像形成用シート |
| GB9625899D0 (en) * | 1996-12-13 | 1997-01-29 | Glaxo Group Ltd | Substances and their uses |
| US6013258A (en) | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
| US7507706B1 (en) * | 1998-12-14 | 2009-03-24 | Genetics Institute, Llc | Cytokine receptor chain |
| KR100659007B1 (ko) * | 1999-02-10 | 2007-02-28 | 미츠비시 웰파마 가부시키가이샤 | 아미드 화합물 및 그 의약으로서의 용도 |
| WO2001077332A2 (en) * | 2000-04-07 | 2001-10-18 | Heska Corporation | Compositions and methods related to canine igg and canine il-13 receptors |
-
2001
- 2001-10-22 WO PCT/US2001/051339 patent/WO2002055100A2/en not_active Ceased
- 2001-10-22 AT AT01989341T patent/ATE405282T1/de not_active IP Right Cessation
- 2001-10-22 AU AU2002243443A patent/AU2002243443A1/en not_active Abandoned
- 2001-10-22 DK DK01989341T patent/DK1333850T3/da active
- 2001-10-22 ES ES01989341T patent/ES2311558T3/es not_active Expired - Lifetime
- 2001-10-22 EP EP01989341A patent/EP1333850B1/en not_active Revoked
- 2001-10-22 DE DE60135481T patent/DE60135481D1/de not_active Expired - Lifetime
- 2001-10-22 JP JP2002555834A patent/JP2004537500A/ja active Pending
- 2001-10-22 EP EP08105062A patent/EP2027867A1/en not_active Withdrawn
-
2008
- 2008-10-08 JP JP2008262301A patent/JP2009046512A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| NZ527113A (en) | Rapid-onset medicament for the treatment of sexual dysfunction | |
| WO2000064441A3 (en) | Compound for use as a medicament for treatment of disorders involving bronchocontraction | |
| WO2002041883A3 (en) | As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation | |
| JP2002522485A5 (enExample) | ||
| JP2002528502A5 (enExample) | ||
| WO2004045593A3 (en) | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy | |
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| JP2001510795A5 (enExample) | ||
| JP2002524415A5 (enExample) | ||
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
| WO2001068125A3 (en) | Methods and compositions for the treatment and prevention of erectile dysfunction | |
| WO2004093881A3 (en) | Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors | |
| WO2005011579A3 (en) | Treatment of dependence withdrawal | |
| WO2002034267A8 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
| JP2003504332A5 (enExample) | ||
| CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| WO2004050025A3 (en) | Combination of ibuprofen and oxycodone for acute pain relief | |
| JP2002523437A5 (enExample) | ||
| CA2313270A1 (en) | Use of deferiprone in treating and preventing iron-induced cardiac disease | |
| WO2005094899A8 (en) | Clusterin antisense therapy for treatment of cancer | |
| SI1677806T1 (sl) | Postopki za zdravljenje akutnega in s preobremenitvijo povzročenega zvina in natega z uporabo hialuronske kisline | |
| JP2003528919A5 (enExample) | ||
| IL194500A0 (en) | Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application |